Olga Genilloud, MEDINA Scientific Director, Head Microbiology Department.
More than 30 years experience in natural products drug discovery obtained in the academic and pharma environments. Since 2009 she leads Fundación MEDINA (https://www.medinadiscovery), a non-for-profit research organization established from former MSD R&D center in Spain focused on natural products research discovery, and coordinates international collaborations with academic and industrial partners to identify novel drugs and high value biotechnological products. Major research interests in bioprospecting microbial sources to untap and characterize novel bioactive molecules and their application in human health. Experience in research projects with international multidisciplinary teams (IMI-ND4BB-ENABLE, IIMENA, LaCaixa Health ND4NTD, H2020-MARBLES), member of different drug discovery international networks (JPIAMR-VRI_IRAADD, GARDP_REVIVE, BEAM Alliance) and research infrastructures (EU-OPENSCREEN; Horizon Europe ISIDORe), with special focus in infectious and neglected diseases. She has more than 180 publications and book chapters, and 18 international patents.

Title of Presentation: Discovery of novel microbial natural products to tackle infectious and neglected tropical diseases

Abstract: Fundación MEDINA is a non-profit organization focused on microbial natural products drug discovery. As reference center in natural products research, MEDINA harbors one the largest microbial collections and natural products libraries. We are engaged in collaborative drug discovery programs worldwide to identify new bioactive compounds to be developed as new treatments that might respond to most urgent needs in infectious and neglected tropical diseases. The presentation will present current research programs with international organizations in the field that will be discussed as examples of our collaboration models.